Cardiac rhythm management devices continue to evolve rapidly in form factor, reliability and lifespan. Even as implantable designs become increasingly compact and functional, they are introducing groundbreaking new elements like leadless pacing and integrated fixation concepts for minimally invasive deployment. Cardiac rhythm management devices such as pacemakers, implantable cardiac defibrillators (ICDs) and CRT devices are all getting smaller, smarter and longer-lasting.
Rise in cholesterol levels, hypertension, and excessive smoking lead to high risks of cardiac disorders, resulting in the growing need for cardiovascular therapeutic instruments such as CRT devices. Governments and organizations in many countries implement various initiatives to educate and help people to make medical decisions, increase public awareness, and improve the quality of life. Pacemakers, ICDs, and CRT devices are used to treat arrhythmias and are considered as a standard treatment option in many countries.
North America is expected to have the largest market share for cardiac rhythm management, due to developed healthcare infrastructure, government initiatives, rising number of death due to cardiovascular diseases, and rising incidence of arrhythmias demanding more cardiac implants. According to a report by the US CDC, more than 75,000 hospitalizations are attributed atrial fibrillation. Also, it highlighted that a large part of the American population suffers from atrial fibrillation. Therefore, it is expected to rise further in the forecast period. Asia-Pacific is another region with high potential for this market, due to rising healthcare expenditure by government, increasing the prevalence of cardiac disorders, and growing per capita income of population in South Asian countries.
The global Cardiac Rhythm Management Devices market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Cardiac Rhythm Management Devices volume and value at global level, regional level and company level. From a global perspective, this report represents overall Cardiac Rhythm Management Devices market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Cardiac Rhythm Management Devices in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Cardiac Rhythm Management Devices manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.
The following manufacturers are covered:
Boston Scientific
Medtronic
St. Jude Medical
Altera
Biotronik
...
Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India
Segment by Type
Implantable Defibrillators
Bi Ventricular Pacemakers
Segment by Application
Hospitals
Clinics
Home Settings
ASCs
Summary:
Get latest Market Research Reports on Cardiac Rhythm Management Devices. Industry analysis & Market Report on Cardiac Rhythm Management Devices is a syndicated market report, published as Global Cardiac Rhythm Management Devices Market Professional Survey Report 2019. It is complete Research Study and Industry Analysis of Cardiac Rhythm Management Devices market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.